Suppr超能文献

一项关于微小病变型特发性肾病综合征患儿血浆激肽生成系统的研究。

A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.

作者信息

Kallen R J, Lee S K

出版信息

Pediatr Res. 1975 Sep;9(9):705-9. doi: 10.1203/00006450-197509000-00004.

Abstract

Although the precise etiologic incitant of the minimal lesion idiopathic nephrotic syndrome of childhood is not known, it is likely that a host mechanism mediates the permeability alterations of the glomerular capillary wall resulting in massive proteinuria. As a first step in examining the possibility that local kinin release may account for the proteinuria in this disorder, two parameters of the plasma kinin-generating system, plasma prekallikrein and kallikrein inhibitor, were assayed during 27 nephrotic episodes in 21 corticosteroid-responsive children. Plasma kallikrein was assayed by means of its esterase activity on a synthetic arginine ester substrate, N-alpha-tosyl-L-arginine methyl ester (TAMe), after activation of Hageman factor by kaolin. This activity, after subtraction of spontaneous arginine esterase activity (i.e., TAMe esterase activity measured in plasma not exposed to kaolin) is derived from prekallikrein. Plasma prekallikrein activity in 11 normal children was 99.6 +/- 2.9 mumol TAMe hydrolyzed/ml plasma/hr (mean +/- SEM). Kallikrein inhibitor was quantified in arbitrary units. Kallifrein inhibitor activity in 11 normal children was 0.94 +/- 0.04 units. During the overt nephrotic syndrome, before initiation of intensive daily corticosteroid treatment, mean values were: prekallikrein, 58.5 +/- 7.24 mumol/ml/hr; and kallikrein inhibitor, 0.35 +/- 0.06 units. After corticosteroid-induced remission occurred, mean values were: plasma prekallikrein, 118.6 +/- 3.2 mumol/ml/hr; and kallikrein inhitor, 0.78 +/- 0.03 mumol/ml/hr. Both parameters were again assayed in 14 of the 21 children after complete cessation of corticosteroid treatment. Plasma prekallikrein was normal, 99.6 +/- 4.8 mumol/ml/hr; but kallikrein inhibitor was still somewhat depressed, 0.84 +/- 0.03 units. A subset of 9 patients had marked depression of plasma prekallikrein to levels less than 20 mumol/ml/hr and essentially undetectable inhibitor activity. Serum alpha-2 macroglobulin was elevated in nephrotic patients: mean value during relapse, 862 +/- 29 mg/100 ml; during corticosteroid-maintaining remission, 615 +/- 29 mg/100 ml. After cessation of corticosteroids, mean serum level was 481 +/- 20 mg/100 ml. The proportional reduction of plasma prekallikrein and kallikrein inhibitor suggested that an enzyme-inhibitor complex formed in vivo, perhaps at a local site of activation in proximity to the glomerular basement membrane. These data suggest that the plasma kinin-generating system may be the host effector mechanism subserving the increased glomerular capillary permeability in the minimal lesion nephrotic syndrome of childhood.

摘要

虽然儿童微小病变型特发性肾病综合征的确切病因尚不清楚,但很可能是一种宿主机制介导了肾小球毛细血管壁的通透性改变,从而导致大量蛋白尿。作为研究局部激肽释放可能是该疾病蛋白尿原因的第一步,我们对21名对皮质类固醇有反应的儿童在27次肾病发作期间的血浆激肽生成系统的两个参数——血浆前激肽释放酶和激肽释放酶抑制剂进行了检测。血浆激肽释放酶通过在高岭土激活Hageman因子后,其对合成精氨酸酯底物N-α-甲苯磺酰-L-精氨酸甲酯(TAMe)的酯酶活性来测定。这种活性在减去自发精氨酸酯酶活性(即在未接触高岭土的血浆中测得的TAMe酯酶活性)后,来自前激肽释放酶。11名正常儿童的血浆前激肽释放酶活性为99.6±2.9μmol TAMe水解/ml血浆/小时(平均值±标准误)。激肽释放酶抑制剂以任意单位进行定量。11名正常儿童的激肽释放酶抑制剂活性为0.94±0.04单位。在明显的肾病综合征期间,在开始每日强化皮质类固醇治疗之前,平均值为:前激肽释放酶,58.5±7.24μmol/ml/小时;激肽释放酶抑制剂,0.35±0.06单位。在皮质类固醇诱导缓解后,平均值为:血浆前激肽释放酶,118.6±3.2μmol/ml/小时;激肽释放酶抑制剂,0.78±0.03μmol/ml/小时。在21名儿童中的14名完全停止皮质类固醇治疗后,再次对这两个参数进行了检测。血浆前激肽释放酶正常,99.6±4.8μmol/ml/小时;但激肽释放酶抑制剂仍略有降低,0.84±0.03单位。9名患者的一个亚组血浆前激肽释放酶明显降低至低于20μmol/ml/小时的水平,且抑制剂活性基本无法检测到。肾病患者的血清α-2巨球蛋白升高:复发期间平均值为862±29mg/100ml;皮质类固醇维持缓解期间为615±29mg/100ml。停止皮质类固醇治疗后,血清平均水平为481±20mg/100ml。血浆前激肽释放酶和激肽释放酶抑制剂的比例降低表明在体内形成了一种酶-抑制剂复合物,可能在靠近肾小球基底膜的局部激活部位。这些数据表明,血浆激肽生成系统可能是儿童微小病变型肾病综合征中肾小球毛细血管通透性增加的宿主效应机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验